An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease.
about
Type VI secretion system: secretion by a contractile nanomachineRibosomally encoded antibacterial proteins and peptides from PseudomonasGenome sequence of E. coli O104:H4 leads to rapid development of a targeted antimicrobial agent against this emerging pathogenAtomic structures of a bactericidal contractile nanotube in its pre- and postcontraction statesShiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategiesDevelopment of an Assay for the Identification of Receptor Binding Proteins from Bacteriophages.Independent Co-Option of a Tailed Bacteriophage into a Killing Complex in PseudomonasShiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinibPeptides as the next generation of anti-infectives.Phage therapy: eco-physiological pharmacology.New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability.Infection therapy: the problem of drug resistance - and possible solutions.Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189.Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile.Tn6350, a Novel Transposon Carrying Pyocin S8 Genes Encoding a Bacteriocin with Activity against Carbapenemase-Producing Pseudomonas aeruginosa.Commensurability between protein nanotubes in contractile ejection nanomachines.Crystal Structures of R-Type Bacteriocin Sheath and Tube Proteins CD1363 and CD1364 From in the Pre-assembled State
P2860
Q26787001-EBA1F924-09AD-400C-889A-AECE664A5E6AQ26992214-8C94CB15-D757-48C5-AD00-3874DAED639BQ28731303-50191133-0208-4CD8-B5D6-98E139596B7FQ30651938-3B4BB8B2-7F92-4DD1-9716-0FB2783A3622Q33402959-47D341A3-C8B4-44DF-BD78-F28E8FF04300Q35892711-A7FB1E9A-B7B5-43B8-9B0F-4A26CB67C605Q35973007-404F1CE5-1C03-4C44-84C1-EB1A0F550EB5Q36382092-274EDEE2-A949-4D19-9ACA-E92EF3233F8DQ38086871-5FEC35C5-F4F8-450D-9B64-C0D5EF29A36BQ38230407-B92C214B-63A8-4ADA-9AF4-48A7250E26DEQ40063929-8D45E894-428F-4682-A5C8-E1CDFFBF89F4Q40122828-3F8241DB-80A0-4551-8E5C-C7BF975A6231Q40184275-0F71D57D-9184-4A78-83EE-020929865017Q41576918-78CACD7B-D2E3-476B-9339-0924C562025CQ42358840-3631A4A5-9A1D-41ED-A310-FA4B223CDAC9Q47278274-05B8A728-4AD9-4D31-812E-754387D4CECBQ58801464-C1A67EA1-1399-4B4B-992D-3B056168B8F2
P2860
An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
An Escherichia coli O157-speci ...... al model of diarrheal disease.
@en
An Escherichia coli O157-speci ...... al model of diarrheal disease.
@nl
type
label
An Escherichia coli O157-speci ...... al model of diarrheal disease.
@en
An Escherichia coli O157-speci ...... al model of diarrheal disease.
@nl
prefLabel
An Escherichia coli O157-speci ...... al model of diarrheal disease.
@en
An Escherichia coli O157-speci ...... al model of diarrheal disease.
@nl
P2093
P2860
P356
P1476
An Escherichia coli O157-speci ...... al model of diarrheal disease.
@en
P2093
Brigid M Davis
Dana Gebhart
David Martin
Dean Scholl
Jennifer L Greenwich
Jennifer M Ritchie
Matthew K Waldor
Roderick T Bronson
Steven R Williams
P2860
P304
P356
10.1128/AAC.05031-11
P407
P577
2011-09-26T00:00:00Z